Edition:
United States

Neogenomics Inc (NEO.OQ)

NEO.OQ on NASDAQ Stock Exchange Capital Market

8.03USD
23 Feb 2018
Change (% chg)

$-0.22 (-2.67%)
Prev Close
$8.25
Open
$8.24
Day's High
$8.34
Day's Low
$7.78
Volume
156,343
Avg. Vol
115,247
52-wk High
$11.55
52-wk Low
$7.08

Chart for

About

NeoGenomics, Inc. is an operator of a network of cancer-focused genetic testing laboratories. The Company operates in Laboratory Testing Segment. This segment delivers testing services to hospitals, pathologists, oncologists, other clinicians and researchers. It has laboratory locations in Ft. Myers and Tampa, Florida; Aliso... (more)

Overall

Beta: 0.49
Market Cap(Mil.): $663.38
Shares Outstanding(Mil.): 80.41
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 29.73 16.31
EPS (TTM): -- -- --
ROI: -- 6.10 35.74
ROE: -- 9.49 17.71

BRIEF-NeoGenomics Reports Q4 Adjusted EPS Of $0.05

* NEOGENOMICS REPORTS REVENUE OF $67.8 MILLION ON 18.7% CLINICAL VOLUME GROWTH AND $10.5 MILLION OF ADJUSTED EBITDA IN THE FOURTH QUARTER OF 2017

Feb 21 2018

BRIEF-Neogenomics Inc files for non-timely 10-Q - SEC filing ‍​

* Neogenomics Inc files for non-timely 10-Q - SEC filing ‍​ Source text: (http://bit.ly/2AozWFk) Further company coverage:

Nov 09 2017

BRIEF-NeoGenomics reports Q3 adj earnings per share of $0.01

* NeoGenomics reports revenue of $63.1 million on 17 percent volume growth and 11 percent reduction in average cost per test in the third quarter of 2017

Oct 25 2017

BRIEF-NeoGenomics sees Q3 revenue of about $63.1 mln

* NeoGenomics announces preliminary quarter 3 results, financial impacts of hurricanes and summary quarter 4 guidance

Oct 12 2017

BRIEF-Neogenomics reports on impact from hurricane Irma

* Hurricane Irma had minimal impacts to Fort Myers, FL facility​

Sep 11 2017

Earnings vs. Estimates